INSIGHTS ON CLINICAL TRIAL DESIGN

• Real-Time Trials Need Real-Time Data You Can Trust

  The FDA just kicked off real-time clinical trials with AstraZeneca and Amgen. But speed means nothing if the underlying data is inconsistent.

• Navigating The Confluence Of AI And Community-Based Trials

  Artificial intelligence (AI) is transforming clinical trials, enhancing efficiency, participation, and diversity, particularly within hybrid trial models.

• Transforming Ophthalmic Assessments For A Mid-Trial Protocol Change

  Discover how a biopharmaceutical company integrated urgent mid-trial mandates across 65 sites, cutting standard onboarding timelines in half while preserving critical enrollment milestones.

• Hybrid Ophthalmic Trials: Splitting Visits Across Home, Hub, And Site

  Hybrid ophthalmic trials combine in-person and remote visits, boosting patient convenience, reducing site burden, and accelerating timelines while maintaining data quality and compliance.

• Clinical Leader Smart Sourcing Solutions Expo: Retention By Design

  9/9/2025

  Enhance participant retention through intuitive UX and real-time site support tools, while seamlessly integrating with IRT, EDC, and third-party platforms.

• Optimizing Pharmacokinetics In Clinical Development

  8/24/2026

  PK tools can do more than model drug behavior — they shape smarter trial designs, better dosing decisions, and lighter burdens on patients. Here's how.

• Are Transportation Failures Really Logistics Problems?

  6/15/2026

  Missed clinical visits stem from fragmented financial workflows — not transport. Integrating payments, approvals, and travel cuts delays, boosts participation, and keeps studies on track.

• Why Bioanalysis Needs To Break Free From Manual Bottlenecks

  9/2/2025

  Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.

• Rethinking Trial Access Through Trust-Driven Design And Local Collaboration

  5/19/2026

  Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.